Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Japan Diabetes Market


6. Japan Diabetes Population

6.1 Type 1 Diabetes
6.2 Type 2 Diabetes


7. Share Analysis - Japan Diabetes Market

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – Japan Market & Users

8.1 Japan - CGM Market by Components

8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market

8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Japan


9. Blood Glucose Device (SMBG) –Japan Market & Users

9.1 Market

9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market

9.2 Test Strips Market

9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes

9.3 Lancet Market

9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes

9.4 Meter Market and Forecast

9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes

9.6 Reimbursement Policies of Blood Glucose Devices in Japan


10. Insulin Pump – Japan Market & Users

10.1 Insulin Pump Market

10.1.1 Type 1 Diabetes Market
10.1.2 Type 2 Diabetes Market

10.2 Insulin Pump User

10.2.1 Type 1 Insulin Pump User
10.2.2 Type 2 Insulin Pump User

10.3 Differentiation Points of Insulin Pump Products in Japan

10.3.1 Animas Vibe
10.3.2 Medtronic 530G with Enlite
10.3.3 InsuletOmniPod
10.3.4 Tandem t: slim
10.3.5 Roche Accu-Chek Combo

10.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

10.4.1 Medtronic
10.4.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
10.4.1.2 Training Model for HCP (HealthCare Professional)

10.5 Insulet Corporation

10.5.1 Training Structure for New Patients - Insulet Corporation

10.6 Animas Corporation

10.6.1 Training Modules for New Patients
10.6.2 Training Modules for HCP (Health Care Professional)

10.7 Tandem Diabetes Care

10.8 Reimbursement Policies Insulin Pump


11. Insulin Pump – Company Analysis

11.1 Medtronic

11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue

11.2 Insulet Corporation

11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue


12. SMBG – Company Analysis

12.1 Abbott Laboratories

12.1.1 Business Overview
12.1.2 Recent Development
12.1.3 Revenue

12.2 DarioHealth Corp

12.2.1 Business Overview
12.2.2 Recent Development
12.2.3 Revenue


13. CGM – Company Analysis

13.1 DexcomInc

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 Roche

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Tandem Diabetes Care

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue



List of Figures

Figure-01: Japan – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: Japan – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: Japan – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: Japan – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: Japan – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: Japan – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: Japan – Glucose Sensor Market (Million US$), 2017 – 2023
Figure-08: Japan – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
Figure-09: Japan – CGM Transmitter Market (Million US$), 2017 – 2023
Figure-10: Japan – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
Figure-11: Japan – CGM User (Thousand), 2017 – 2023
Figure-12: Japan – Forecast for CGM User (Thousand),2023 – 2028
Figure-13: Japan – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: Japan – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: Japan – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: Japan – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: Japan – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: Japan – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: Japan – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: Japan – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: Japan – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: Japan – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: Japan – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: Japan – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: Japan – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: Japan – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: Japan – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: Japan – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: Japan – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: Japan – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: Japan – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: Japan – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: Japan – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-34: Japan – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-35: Japan – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-36: Japan – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-37: Japan – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-38: Japan – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-39: Japan – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-40: Japan – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-41: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-42: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-43: Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-44: Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-45: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-46: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-47: DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
Figure-48: DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-49: Dexcom Inc – Global Revenue (Million US$), 2017 – 2022
Figure-50: Dexcom Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-51: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-52: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-53: Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
Figure-54: Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables

Table-01: Japan – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Japan – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028